CFTR mutation in an Arab patient: Clinical and functional features of 875+1G→A/875+1G→A genotype  Elide Spinelli, Manuela Seia, Paola Melotti, Eleonora.

Slides:



Advertisements
Similar presentations
Use of the insulin pump in treat cystic fibrosis related diabetes Dana S. Hardin, Julie Rice, Mark Rice, Randall Rosenblatt Journal of Cystic Fibrosis.
Advertisements

J.H.K. Hull, W. Tucker, A.G. Hatrick, R.K. Knight, T.B.L. Ho 
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Poor growth in an infant with cystic fibrosis due to an antenatal perforation and incomplete bowel obstruction  Isobel Brookes, Maya Desai, Gillian Duthie,
Effects of ivacaftor on severely ill patients with cystic fibrosis carrying a G551D mutation  Helge Hebestreit, Annette Sauer-Heilborn, Rainald Fischer,
The prevalence of “risky behaviour” in adults with cystic fibrosis
Consequences of partial duplications of the human CFTR gene on cf diagnosis: Mutations or ectopic variations  Ayman El-Seedy, Marie-Claude Pasquet, Thiery.
Nasal potential difference measurements in diagnosis of cystic fibrosis: An international survey  Lutz Naehrlich, Manfred Ballmann, Jane Davies, Nico.
P. Whitaker, N. Shaw, J. Gooi, C. Etherington, S. Conway, D. Peckham 
Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function  Fredrick Van Goor, Haihui Yu, Bill.
Is infection with hypermutable Pseudomonas aeruginosa clinically significant?  Adi Auerbach, Eitan Kerem, Marc Victor Assous, Elie Picard, Maskit Bar-Meir 
Bilateral midshaft femoral fractures in an adolescent baseball player
Cystic fibrosis: A new mutation in the Lebanese population
R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J
J.H.K. Hull, W. Tucker, A.G. Hatrick, R.K. Knight, T.B.L. Ho 
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Successful treatment of cepacia syndrome
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Frank J. Accurso, Fredrick Van Goor, Jiuhong Zha, Anne J
Cirrhosis and other liver disease in cystic fibrosis
Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin 
Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection  Marita Gilljam, Henrik Scherstén, Martin Silverborn, Bodil.
The ease of breathing test tracks clinical changes in cystic fibrosis
Delayed publication of clinical trials in cystic fibrosis
Expression of the inflammatory regulator A20 correlates with lung function in patients with cystic fibrosis  Catriona Kelly, Mark T. Williams, J. Stuart.
Controlled clinical trials in cystic fibrosis — are we doing better?
Cynthia M. Ward, Tara Brinkman, Keith J. Slifer, Shruti M. Paranjape 
Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar 
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Cystic fibrosis mortality trend in Italy from 1970 to 2011
Clinical presentation of mild cystic fibrosis in a Serbian patient homozygous for the CFTR mutation c G>A  Aleksandra Nikolic, Nedeljko Radlovic,
A.H. Gifford  Journal of Cystic Fibrosis 
Demographics of glucose metabolism in cystic fibrosis
Inhalation solutions — Which ones may be mixed
Physiologic endpoints for clinical studies for cystic fibrosis
Characterisation of mutations and genotype–phenotype correlation in cystic fibrosis: Experience from India  Shivaram S. Shastri, Madhulika Kabra, Sushil.
Sophia L. Markantonis, Anna Katelari, Eleni Pappa, Stavros Doudounakis 
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?
Ultrasound and magnetic resonance imaging assessment of joint disease in symptomatic patients with cystic fibrosis arthropathy  G. Fitch, K. Williams,
Nasal polyposis in lung transplant recipients with cystic fibrosis
Elliott C. Dasenbrook, Gregory S. Sawicki  Journal of Cystic Fibrosis 
Chee Y. Ooi, Peter R. Durie  Journal of Cystic Fibrosis 
Whole blood fatty acid analysis with micromethod in cystic fibrosis and pulmonary disease  Patrizia Risé, Sonia Volpi, Claudio Colombo, Rita Francesca.
D.Y.F. Mak, J. Sykes, A.L. Stephenson, L.C. Lands 
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United.
Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic  Amanda L. Griffiths, Danielle F. Wurzel,
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
F. Vermeulen, P. Lebecque, K. De Boeck, T. Leal 
Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis  M.N. Hurley, A.H. Amin Ariff, C. Bertenshaw,
V. Thompson, N. Mayer-Hamblett, M. Kloster, D. Bilton, P.A. Flume 
H. White, A.M. Morton, S.P. Conway, D.G. Peckham 
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
L. Uppaluri, S.J. England, T.F. Scanlin  Journal of Cystic Fibrosis 
D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher 
CFTR modulators and pregnancy: Our work has only just begun
‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis
Beta-lactam allergy in adults with cystic fibrosis
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
CFTR, investigated with the two-electrode voltage-clamp technique: the importance of knowing the series resistance  Georg Nagel  Journal of Cystic Fibrosis 
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) in Chinese patients with congenital bilateral absence of vas deferens  Hongjun.
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Theresa A. Laguna, Scott D. Sagel, Marci K. Sontag, Frank J. Accurso 
Absence of a gender gap in survival
Presentation transcript:

CFTR mutation in an Arab patient: Clinical and functional features of 875+1G→A/875+1G→A genotype  Elide Spinelli, Manuela Seia, Paola Melotti, Eleonora Marchina, Rita Padoan  Journal of Cystic Fibrosis  Volume 8, Issue 4, Pages 282-284 (July 2009) DOI: 10.1016/j.jcf.2009.05.003 Copyright © 2009 European Cystic Fibrosis Society Terms and Conditions

Fig. 1 The patient's family tree. Journal of Cystic Fibrosis 2009 8, 282-284DOI: (10.1016/j.jcf.2009.05.003) Copyright © 2009 European Cystic Fibrosis Society Terms and Conditions

Fig. 2 NPD measurements. The agents indicated at the bottom were added at the times (seconds) shown on the x axis. On the y axis, PD are expressed in mV. The graph was obtained during measurements of the left nostril and is representative of both nostrils. Journal of Cystic Fibrosis 2009 8, 282-284DOI: (10.1016/j.jcf.2009.05.003) Copyright © 2009 European Cystic Fibrosis Society Terms and Conditions